retatrutide glp-1 gip glucagon triple agonist Structural insights into the agonism at GLP-1R, GIPR and GCGR manifested by Cagrilintide vs Retatrutide Compared |

For this population-based study, researchers used medical records from about 45 million people in the United States listed in the TriNetX real-time federated health research network who all had at least one outpatient or inpatient doctor visit between 2011 and 2023

| What this means if youre on Mounjaro or Wegovy | Limitations of the TRIUMPH-1 results | Frequently asked questions | Take home message A Phase 3 trial has found that the experimental weight-loss drug retatrutide produced an average weight loss of up to 30.3% in adults living with obesity, the highest figure reported so far for a weight-loss injection

Prepayment : Cash-pay practices that charge upfront for visits see dramatically lower no-shows

Craig Mortensen, DC, IFMCP, QME | June 2026 We hear about peptides and GLP-1s everywhere these days, and the terms are often used interchangeably

Since these receptors are present in various organ systems and in the brain, their roles in satiety and appetite regulation, as well as neuroinflammation and neuroplasticity, must be considered